Sep 8, 2021BioMarin AAV gene therapy trial haltedThe FDA has halted testing of BioMarin's AAV based gene therapy drug after liver cancer developed in treated mice. BioMarin's BMN_307...
Sep 7, 2021CSO presented at CTGTAC The Cellular, Tissue and Gene Therapies Advisory Committee held a virtual public meeting meeting on 2-3rd September on the toxicity risks...
Sep 7, 2021AAV Integration Roundtable The ASGCT sponsored a roundtable event of talks by industry experts on AAV integration. These discussions were extremely interesting and...
Aug 31, 2021We have a new Principal Scientist Saqlain Suleman has joined the TestAVec team as Principal Scientific Officer. He will be working to develop and lead projects in...
Aug 31, 2021Bluebird halts gene therapy trialBluebird Bio has halted a phase 3 gene therapy clinical trial against cerebral adrenoleukodystrophy. This trial use lentiviral vectors...